Skip to content

MR imaging for the detection and evaluation of periodontal diseases

MR imaging for the detection and evaluation of periodontal diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00020761
Enrollment
80
Registered
2020-04-06
Start date
2018-10-29
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K05.3 K05.2

Interventions

Group 1: healthy control subjects Group 2: Patients with diagnosed periodontitis receive MRI scan and clinical periodontitis-specific examination per patient - before treatment and 3 months after comp

Sponsors

Klinikum rechts der Isar, Abteilung für Diagnostische und Interventionelle Neuroradiologie, TU München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Included were both, male and female patients with diagnosed, periodontitis as well as healthy control subjects (in the context of sequence optimization and as a healthy comparison collective). Diagnosis of generalized periodontitis was made when clinical periodontal attachment loss was present at >2 interdental sites at non-adjacent teeth and/or a probing pocket depth of >3mm at oral or lingual sites. At least 30% of teeth had to be affected by periodontitis. None of the healthy control subjects and the periodontitis patients received periodontal treatment within the past six month.

Exclusion criteria

Exclusion criteria: Patients with contraindications for an MRI examination (e.g. pacemaker, implanted defibrillator, artificial heart valves, cochlear implants, metal splinters, insulin pumps) were excluded. Further exclusion criteria were patients with pronounced claustrophobia, psychomotor agitation, pregnant as well as breastfeeding women and patients with a metastatic, malignant underlying disease.

Design outcomes

Primary

MeasureTime frame
Signal changes in MRI (signal-to-noise-ratio as well as volume of changes in mm3 - clinically determined parameters (bleeding on probing, pocket probing depth)

Secondary

MeasureTime frame
bone resorption, attachment loss

Countries

Germany

Contacts

Public ContactMonika Probst

Klinikum rechts der Isar, Abteilung für diagnostische und interventionelle Neuroradiologie, TU München

monika.probst@tum.de08941404651

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026